LRRK2 mouse models: dissecting the behavior, striatal neurochemistry and neurophysiology of PD pathogenesis
- 8 February 2017
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 45 (1), 113-122
- https://doi.org/10.1042/bst20160238
Abstract
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of familial Parkinson's disease (PD), resembling the sporadic disorder. Intensive effort has been directed toward LRRK2 mouse modeling and investigation, aimed at reproducing the human disease to inform mechanistic studies of pathogenesis and design of neuroprotective therapies. The physiological function of LRRK2 is still under exploration, but a clear role in striatal neurophysiology and animal behavior has emerged. Alterations in LRRK2 impair dopamine (DA) transmission, regulation and signaling, in addition to corticostriatal synaptic plasticity. Consistently, several subtle abnormalities in motor and nonmotor abilities have been demonstrated in LRRK2 genetic mouse models, generally paralleling preclinical symptoms of early DA dysfunction. However, the variability in model design and phenotypes observed requires a critical approach in interpreting the results, adapting the model used to the specific research question. Etiologically appropriate knockin mice might represent the ultimate animal model in which to study early disease mechanisms and therapies as well as to investigate drug effectiveness and off-target consequences.Keywords
This publication has 70 references indexed in Scilit:
- Genetics and genomics of Parkinson’s diseaseGenome Medicine, 2014
- 100 years of Lewy pathologyNature Reviews Neurology, 2012
- LRRK2 I2020T mutation is associated with tau pathologyParkinsonism & Related Disorders, 2012
- Toward a redefinition of Parkinson's diseaseMovement Disorders, 2012
- Genetics of Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Non-motor symptoms of Parkinson's disease: diagnosis and managementThe Lancet Neurology, 2006
- LRRK2G2019S as a Cause of Parkinson's Disease in North African ArabsNew England Journal of Medicine, 2006
- LRRK2G2019S as a Cause of Parkinson's Disease in Ashkenazi JewsNew England Journal of Medicine, 2006
- Lrrk2 and Lewy body diseaseAnnals of Neurology, 2006
- Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic PathologyNeuron, 2004